News about PaperPanda, Open Access, and Research
Older adults make up a hefty proportion of cancer patients but a much smaller slice of clinical trial participants—a long-standing and vexing problem the U.S. Food and Drug Administration (FDA) wants drug companies to tackle. The agency yesterday released recommendations urging companies to boost representation of people over 65 years old, and especially over 75. … Read more
CONSERVATION Koalas declared endangered as wolves get reprieve The iconic koala is now endangered in parts of Australia, the government announced last week. The status of the marsupial was changed from threatened, on the advice of an expert panel that blamed dwindling numbers on habitat loss from land clearing and bush fires, droughts and heat … Read more
In the spring of 2017 I was serendipitously invited to what initially seemed to be the wrong scientific meeting. The invitation came thirdhand, and the details were murky but intriguing. I took a car to a train to a downtown hotel where I wound my way through a series of conference rooms before a sign … Read more
By Clare Wilson A participant in a clinical trial for aducanumab Kayana Szymczak/New York Times/Redux/eyevine EXPECT to see debate over a new medicine to treat Alzheimer’s disease, called aducanumab, continue into 2022. Approved in the US last June, it is the first drug designed to treat a possible cause of this form of dementia, rather than the symptoms. … Read more
Rapid Covid home tests are more likely to give a false negative with the heavily-mutated Omicron variant compared to earlier strains, the US Food and Drug Administration (FDA) said Tuesday. The news comes as the country is facing a massive surge in cases that experts say is being under-captured as a result of a … Read more
The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization for the potent oral antiviral regimen developed by Pfizer to treat COVID-19, making it just the second such drug to receive a regulatory greenlight by any country. Last month, the United Kingdom authorized the use of a Merck-made pill that appears much … Read more
The world’s first injectable medication to reduce the risk of acquiring HIV has been approved by the Food and Drug Administration (FDA), the agency announced Monday (December 20). The injectable drug – called Apretude or its generic name, “cabotegravir extended-release injectable suspension” – provides an alternative to daily pills for HIV prevention, such as Truvada and Descovy. These pills are … Read more